Correlation Between AroCell AB and Kancera AB

Can any of the company-specific risk be diversified away by investing in both AroCell AB and Kancera AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AroCell AB and Kancera AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AroCell AB and Kancera AB, you can compare the effects of market volatilities on AroCell AB and Kancera AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AroCell AB with a short position of Kancera AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of AroCell AB and Kancera AB.

Diversification Opportunities for AroCell AB and Kancera AB

0.92

Correlation Coefficient

AroCell AB  Kancera AB

Almost no diversification

The 3 months correlation between AroCell and Kancera is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding AroCell AB and Kancera AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kancera AB and AroCell AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AroCell AB are associated (or correlated) with Kancera AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kancera AB has no effect on the direction of AroCell AB i.e., AroCell AB and Kancera AB go up and down completely randomly.

Pair Corralation between AroCell AB and Kancera AB

Assuming the 90 days trading horizon AroCell AB is expected to generate 0.38 times more return on investment than Kancera AB. However, AroCell AB is 2.61 times less risky than Kancera AB. It trades about -0.18 of its potential returns per unit of risk. Kancera AB is currently generating about -0.1 per unit of risk. If you would invest  63.00  in AroCell AB on September 5, 2024 and sell it today you would lose (21.00) from holding AroCell AB or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

AroCell AB  vs.  Kancera AB

AroCell AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AroCell AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Kancera AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with AroCell AB and Kancera AB

The main advantage of trading using opposite AroCell AB and Kancera AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AroCell AB position performs unexpectedly, Kancera AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kancera AB will offset losses from the drop in Kancera AB's long position.

The idea behind AroCell AB and Kancera AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.